Concepedia

Tianping Luo

TL

Statistics

Publications

5

Citations

122

H-Index

5

Active since

2010

Affiliations

Changzhou No.2 People's Hospital(Current)

Nanjing Medical University

Hangzhou Hospital of Traditional Chinese Medicine

Tianping Luo is an author at Changzhou No.2 People's Hospital specializing in hepatocellular carcinoma pathogenesis, molecular oncology, and oncology.

ORCID

Publications per year

2010–2020

5

Publications

5

<p>lncRNA PCBP1-AS1 Aggravates the Progression of Hepatocellular Carcinoma via Regulating PCBP1/PRL-3/AKT Pathway</p>

Tianping Luo, Yuan Gao, Guangyan Zhangyuan et al. · Cancer Management and Research · 2020 · 34 citations · Full text

, , +17

IGF2BP3 and miR191‑5p synergistically increase HCC cell invasiveness by altering ZO‑1 expression

Yuan Gao, Tianping Luo, Xiwu Ouyang et al. · Oncology Letters · 2020 · 29 citations · Full text

, , +17

Serine protease HtrA1 expression in human hepatocellular carcinoma.

Feng Zhu, Lei Jin, Tianping Luo et al. · PubMed · 2010 · 26 citations

, , +12

Suppression of CUGBP1 inhibits growth of hepatocellular carcinoma cells

Yong Liu, Hai Huang, Bo Yuan et al. · Clinical and investigative medicine · 2014 · 18 citations · Full text

, , +17

Down‐regulation of G protein‐coupled receptor 137 by RNA interference inhibits cell growth of two hepatoma cell lines

Xin Shao, Yong Liu, Hai Huang et al. · Cell Biology International · 2014 · 15 citations

, , +17

1–5 of 5